Stratified analysis identifies HIF-2 α as a therapeutic target for highly immune-infiltrated melanomas.
Huang AY, Burke KP, Porter R, Meiger L, Fatouros P, Yang J, Robitschek E, Vokes N, Ricker C, Rosado V, Tarantino G, Chen J, Aprati TJ, Glettig MC, He Y, Wang C, Fu D, Ho LL, Galani K, Freeman GJ, Buchbinder EI, Hodi FS, Kellis M, Boland GM, Sharpe AH, Liu D.
Huang AY, et al. Among authors: fu d.
bioRxiv [Preprint]. 2024 Oct 30:2024.10.29.620300. doi: 10.1101/2024.10.29.620300.
bioRxiv. 2024.
PMID: 39554029
Free PMC article.
Preprint.